When:
Monday, Mar 26, 2018 8:00a -
Wednesday, Mar 28, 2018 5:00p

Where:
Revere Hotel Boston Common
200 Stuart Street
Boston, MA 02116

Admission:
$1795

Categories:
Lectures & Conferences

Event website:
https://go.evvnt.com/174423-0

When over 80% of APIs in development are poorly water-soluble, drug companies must rely increasingly on new formulation and delivery strategies to maximize bioavailability. ExL's 7th Drug Formulation, Solubility and Bioavailability conference helps you recognize the precise thresholds where an enabled formulation becomes necessary, as well as determine which method to use and how to predict and gauge its success. This event provides you with an unmatched focus on the latest technologies and team skills that you need to gather and interpret first-in-human results and accelerate time-to-market.

Top Five Reasons to Attend

1. Breakthroughs in oral biologics delivery
2. Deeper understanding of self-association to enhance formulation performance
3. Strategies to design, interpret and rank the performance of the next generation of predictive models
4. Skills for getting long-term stability answers in the shortest time possible
5. Latest insights on 3D printing applications for enabled formulations

**FULL-DAY SEMINAR ON ADVANCES IN DRUG DELIVERYFeaturing oral biologics, long-acting injectables, amorphous biologics, depot microparticles, targeted tissue delivery – and much more!

URLs:
Brochure: https://go.evvnt.com/174423-1
Booking: https://go.evvnt.com/174423-2

Prices:
Conference Only - Early Bird Pricing - Register by February 9, 2018: USD 1795,
Conference + Seminar - Early Bird Pricing - Register by February 9, 2018: USD 2495,
Conference Only - Standard Pricing: USD 1995,
Conference + Seminar - Standard Pricing: USD 2695,
Conference Only - Onsite Pricing: USD 2195,
Conference + Seminar - Onsite Pricing: USD 2895

Speakers: Rossitza Alargova Director, Formulations, INFINITY PHARMACEUTICALS, Gail Dempsey EOC and Director, Manufacturing Technologies, PIEDMONT ANIMAL HEALTH, Rakesh Dixit Vice President, RandD, Global Head, Biologics Safety, MEDIMMUNE, Emilija Fredro-Kumbaradzi Manager, Biowaivers and Biocorrelations, APOTEX, Ruchi Gupta Scientist, MEDIMMUNE

Share this event

Add to:

26/03/2018 08:00:00 28/03/2018 17:00:00 15 7th Drug Formulation, Solubility and Bioavailability When over 80% of APIs in development are poorly water-soluble, drug companies must rely increasingly on new formulation and delivery strategies to maximize bioavailability. ExL's 7th Drug Formulati... Revere Hotel Boston Common, Boston, MA 02116 Organizer Organizer e-mail false DD/MM/YYYY Reddit